Weight Loss Telehealth in New York 2026 14 Providers Compared, Ranked, and Priced

New York residents have access to 14 weight loss telehealth providers in 2026. Three platforms you might find mentioned elsewhere, Clinic Secret, Nurx, and UrWay Health, are not among the 14 platforms compared on this page. If you want to check eligibility with any of those three, visit their own sites directly. The good news is that the 14 that do serve New York cover every price point, every medication type, and every level of clinical support you might be looking for.

The full list includes TrimRx, Medvi, Ro, Strut, Shed, Fridays, Eden, HealthRx, Sprout Health, Peter MD, Skinny.Rx, Hers, Hims, and Sesame Care. These range from budget-focused compounding platforms charging under $200 a month to clinical-grade services that will help you fight your insurer for brand-name Wegovy. The right choice depends almost entirely on whether you have insurance, what medication you are targeting, and how much hand-holding you want along the way.

New York is one of the better states to be in if you are pursuing GLP-1 weight loss treatment. Compounded semaglutide is offered here through licensed 503B outsourcing facilities, mainly because it costs far less than brand-name Wegovy now that the FDA has declared the shortage resolved (February 2025). Tirzepatide in both brand-name Zepbound and compounded forms is also accessible. Phentermine is available in New York, though the telehealth prescribing rules around it are worth understanding before you assume any platform can hand it to you over a video call.

If you want the lowest possible monthly cost for compounded semaglutide in New York, HealthRx or Strut is the answer, at $99 per month all-inclusive. Medvi runs $299 per month, the highest price of the 14 platforms in the state, but it bundles in free dietician visits and ongoing care coaching. That price covers your medication, your provider visit, and ongoing follow-up. Medvi has a 9.2 out of 10 rating. It is not a platform that drowns you in lifestyle content or app features, it is focused on getting you the medication and keeping your costs manageable.

If you want help using your insurance to get brand-name Wegovy or Ozempic, Ro is the better fit. Ro has built out real insurance navigation infrastructure, which is not something most telehealth platforms bother with. If you have commercial insurance or are on a plan through a New York employer, Ro's team will actually work through the prior authorization process with you. Given that Wegovy can run $1,300 to $1,500 per month without coverage, that support is worth something real. Ro also covers a wide treatment range beyond weight loss, which matters if you want a single platform for multiple health concerns.

If you want insurance accepted for the visit itself, Sesame Care is worth knowing about. None of the 14 platforms compared here functions as a full primary care practice that folds weight loss into general checkups, but Sesame Care accepts insurance for weight loss visits and lets you pay per visit instead of a subscription. For New Yorkers who have solid commercial insurance but are unsure how to use it for weight loss treatment, Sesame Care will give you more traction than a cash-only compounding service.

New York residents can access all of the major GLP-1 weight loss medications in 2026. Brand-name Wegovy and Ozempic are prescribable here, compounded semaglutide is available through licensed 503B pharmacies, brand-name Zepbound is available, and compounded tirzepatide is accessible through the same pharmacy channels. Compounded versions filled a real gap while the shortage ran. The FDA closed the semaglutide listing in February 2025, so what keeps them on the table in New York now is the clinical case documented for the prescription.

Compounded semaglutide from a 503B licensed outsourcing facility is not a gray-market product. These facilities are FDA-registered and subject to federal oversight. The compound itself contains semaglutide, the active ingredient in Wegovy, but is not the branded product and is not FDA-approved, which is how the pricing can be so much lower. The key question to ask any platform is whether they are sourcing from a 503B facility specifically, not just any compounding pharmacy.

Tirzepatide in New York is available in both forms as well. Zepbound is the brand-name version approved for weight loss, and some providers, particularly those with insurance navigation capability like Ro, can help you get it covered. Compounded tirzepatide is also accessible, and platforms like Medvi and Sprout Health are working with it for patients who cannot get brand-name coverage. If you have searched for affordable tirzepatide in New York, the compounded route through a reputable telehealth platform is currently your most realistic path to a price under $300 a month.

Liraglutide, phentermine, metformin, and bupropion-naltrexone round out the medication options in New York. Phentermine deserves a specific note. It is a controlled substance, and while New York does not have the same blanket restrictions some states have placed on telehealth prescribing of controlled substances, not every platform on this list will prescribe it remotely. If phentermine is what you are specifically researching, ask the platform directly before you pay for a consult. Sesame Care, which operates more like traditional primary care, is more likely to have a straightforward pathway for this than a GLP-1-only compounding platform.

The price range across New York's 14 providers is wide enough that the platform you choose matters enormously. On the low end, HealthRx and Strut price compounded semaglutide at $99 per month all-inclusive. Medvi runs $299 per month, the most expensive of the 14, and adds free dietician visits and care coaching. Skinny.Rx sits far below that at $149.25 per month and offers straightforward monthly pricing without a lot of add-ons. These are the options for New Yorkers who are uninsured or whose insurance explicitly excludes weight loss medications, which is still the case with many employer-sponsored plans.

Mid-tier options like Sprout Health and Shed typically run $200 to $350 a month. These platforms tend to include nutritionist support or behavioral coaching in that price, so you are getting more than just the medication. Hims also offers weight loss treatment and is known for competitive pricing, with a 9.4 out of 10 rating. For women, Hers covers weight loss alongside other health services and is priced similarly.

Brand-name Wegovy without insurance in New York runs approximately $1,300 to $1,500 per month at retail pharmacies. Ozempic, which is prescribed off-label for weight loss but is technically a diabetes drug, can run $900 to $1,100 without coverage. If you have insurance and a BMI of 30 or above, or a BMI of 27 or above with a documented comorbidity like hypertension or type 2 diabetes, you meet the standard clinical threshold for coverage consideration. The fight is getting your insurer to agree, which is where Ro earns its value.

Sesame Care uses a pay-per-visit model with no subscription, which can be a good fit if you already have a GLP-1 prescription and just need follow-up consultations without committing to a monthly platform fee. Peter MD sits at a higher price point and is better suited for people who want a physician-led protocol across multiple health areas, not just weight loss in isolation.

New York is one of the states where insurance coverage for weight loss medications has been expanding, but it is still inconsistent. New York Medicaid covers mental health services for an expanded population and has made some moves toward covering GLP-1s, but coverage for weight loss specifically on Medicaid depends on diagnosis codes and documentation. If you are on Medicaid in New York and have a Type 2 diabetes diagnosis, Ozempic has a much clearer coverage pathway than Wegovy used to. The landscape has shifted somewhat in 2026 as Wegovy's obesity indication has become harder for insurers to categorically deny.

For commercial insurance through a New York employer or a plan purchased on the NY State of Health exchange, the picture varies by plan. Large employer plans and union plans in New York have been more likely to include GLP-1 obesity coverage than small business plans. If your plan has a prior authorization requirement, which most do for Wegovy or Zepbound, you will need documentation from a provider showing your BMI, your comorbidities, and evidence that you have tried other interventions. Ro is set up to help you build that case.

Sesame Care accepts insurance directly for weight loss visits, so treatment through Sesame Care can happen without paying cash for every appointment. This is different from a cash-pay compounding platform, which will give you medication quickly but will not help you work through insurance paperwork. If you have good insurance and time to spend on the prior auth process, the insurance route has the potential to reduce your monthly cost to a copay. If you need to start now and do not want to wait, the cash-pay compounding route gets you moving in days.

For weight loss telehealth, your physical location within New York matters less than you might think. All 14 providers on this list serve New York state, not just the metro area. Telehealth licensing in New York is statewide, so a provider consultation on any of these platforms is equally available whether you are in Buffalo, Syracuse, Albany, or the Bronx. The medications ship to your address, so pharmacy access in your zip code is not a barrier.

That said, there are some practical differences. New York City residents have more local pharmacy options to check by hand if your dose tier is not on the shelf, including larger hospital-affiliated pharmacies that may have Wegovy when CVS or Rite Aid does not. Upstate New York residents may find that shipping times for compounded medications from out-of-state 503B pharmacies run an extra day or two. This is a minor factor for most people, but if you are about to run out of medication, it is worth ordering ahead.

One area where location within New York can actually matter is cost of living as it relates to in-person alternatives. Manhattan has numerous weight loss clinics, medical spas, and obesity medicine specialists who offer in-person GLP-1 programs at significant premiums. If you have been quoted $500 or more per month by an in-person clinic in New York City, you should know that Skinny.Rx, Sprout Health, and Medvi offer telehealth programs that run $149.25 to $299 per month using the same medications and the same clinical standards. The convenience of in-person is real, but the price markup in New York City is considerable.

New York has specific telehealth regulations that affect how your first visit and prescription work. In New York, a valid prescriber-patient relationship must be established before a controlled substance can be prescribed via telehealth. Phentermine is classified as a Schedule IV controlled substance, which means platforms that prescribe it remotely need to comply with both state and federal requirements. New York has not passed blanket restrictions on telehealth prescribing of Schedule IV substances the way some other states have, but individual platforms have their own policies about whether they will prescribe phentermine on a first telehealth visit.

For non-controlled GLP-1 medications like semaglutide and tirzepatide, New York telehealth prescribing is more straightforward. A synchronous or asynchronous telehealth visit is sufficient to establish the prescriber relationship, and most of the platforms on this list use a combination of intake questionnaire and video or async review to get you a prescription within 24 to 72 hours. This is consistent across the state.

New York's medical board also has specific requirements for telehealth providers operating in the state. Platforms serving New York residents must have licensed New York providers on their clinical staff or must work with providers who hold a valid New York medical license. This is worth checking if you ever come across a weight loss platform that is not on this list, since some platforms operate legally in other states but have not gone through the credentialing required to serve New York. Every platform on this list of 14 has cleared that bar.

Most New Yorkers researching weight loss telehealth end up comparing Medvi and Ro at some point, and the decision comes down to what you want included. Medvi is the bundled option, not the cheap one: at $299 a month it is the most expensive of the 14 platforms serving New York, and that single fee covers compounded semaglutide, your provider visits, free dietician visits, and care coaching, with a 9.2 out of 10 rating behind it. If you want that support in one place and you are not shopping on price, Medvi is the right call. If price is what decides it, HealthRx and Strut start at $99 a month.

Ro wins on insurance navigation and brand-name access. If you have commercial insurance through a New York employer and want Wegovy specifically rather than a compounded version, Ro has the clinical and administrative infrastructure to help you make that happen. Ro also covers ED and hair loss on the same platform, which matters if you want a single telehealth relationship for multiple concerns. Its 9.3 out of 10 rating reflects a platform that handles complexity well.

The one case where neither Medvi nor Ro is necessarily the top choice is if you want one of the highest-rated platforms by raw score and you are open to broader features. Both Hims and Strut hold a 9.4 out of 10 rating. Hims covers weight loss alongside its core ED and hair loss business, and its mobile experience is well regarded. Strut is more specialized around compounded formulations. For weight loss specifically as your primary goal, Medvi and Ro remain the cleaner recommendations, but Hims is worth a look if you want a larger platform.

The process across all 14 New York providers follows a similar pattern. You complete an intake form online covering your weight, height, medical history, and any current medications. A licensed New York provider reviews your information and either approves a prescription or schedules a brief video consultation. For most GLP-1 platforms, the initial review takes anywhere from a few hours to 48 hours. Your medication is then shipped from a licensed pharmacy directly to your New York address.

Before you start, you should know your BMI. The clinical standard threshold for GLP-1 prescribing is a BMI of 30 or above for most medications, or 27 or above if you have a documented comorbidity like high blood pressure, sleep apnea, high cholesterol, or Type 2 diabetes. If you are close to the threshold, being prepared with recent lab work or a note from your primary care doctor can speed up the process. If you have a BMI well above 30, most platforms will approve you quickly without additional documentation.

The titration schedule for semaglutide typically starts at 0.25mg per week for the first four weeks before increasing. Sprout Health is specifically set up to support you through that process with check-ins and coaching. If you are the type of person who will want someone to talk to when you are dealing with nausea or fatigue in weeks two and three, choose a platform that has that support built in. If you just want the medication and are comfortable managing the process yourself, Skinny.Rx or HealthRx will get you what you need at a lower cost.